国际眼科纵览 ›› 2022, Vol. 46 ›› Issue (2): 157-161.doi: 10.3760/ cma.j.issn.1673-5803.2022.02.011

• 综述 • 上一篇    下一篇

泪腺腺样囊性癌相关的小RNA及其调控作用

邵雅琪  马建民   

  1. 首都医科大学附属北京同仁医院  北京同仁眼科中心  眼科学与视觉科学北京市重点实验室 100730
  • 收稿日期:2021-04-19 出版日期:2022-04-22 发布日期:2022-04-24
  • 通讯作者: 马建民,Email:jmma@sina.com
  • 基金资助:
    北京市自然科学基金(7222025);北京市医院管理中心“登峰”人才计划(DFL20190201)  

MicroRNA and their regulating effects in lacrimal gland adenoid cystic carcinoma

Shao Yaqi, Ma Jianmin   

  1. Beijing  Key Laboratory of Ophthalmology and Visual Science; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2021-04-19 Online:2022-04-22 Published:2022-04-24
  • Contact: Ma Jiamin, Email:jmma@sina.com
  • Supported by:
    Beijing Natural Science Foundation (7222025); Special Fund for "Peak Climbing" Plan of Beijing Hospital Management Center (DFL20190201)  

摘要: 泪腺腺样囊性癌(lacrimal gland adenoid cystic carcinoma,LGACC)是一种常见的、发生于泪腺的恶性上皮性肿瘤,其复发率和转移率均较高。多种小RNA(miRNA)在LGACC的发生、发展中起重要作用。miR-24-3p过表达可降低LGACC中PRKCH的表达以促进p53/p21表达,从而抑制肿瘤的侵袭。miR-93-5p通过调控Wnt信号通路,靶向下调乳腺癌转移抑制因子1L,而促进LGACC细胞上皮细胞-间充质转化、迁移、侵袭和增生。LGACC中的miR-181a-5p表达上调,也是LGACC细胞增生和迁移的原因之一。(国际眼科纵览,2022, 46:157-161)


关键词: 泪腺腺样囊性癌, 小RNA 

Abstract: Lacrimal gland adenoid cystic carcinoma(LGACC) is a common malignant epithelial tumor of  lacrimal gland, which has high recurrence rate and metastasis rate. In recent years, it has been found that a variety of microRNAs play an important role in the occurrence and development of LGACC. Overexpression of miR-24-3p can promote the expression of p53 / p21 by reducing the expression of PRKCH in LGACC, so as to inhibit tumor invasion. MiR-93-5p regulates Wnt signaling pathway and down regulates breast cancer metastasis suppressor 1 (BRMS1) L, and promotes epithelial mesenchymal transition (EMT), migration, invasion and proliferation of LGACC cells. The up-regulated expression of miR-181a-5p in LGACC is also one of the reasons for the proliferation and migration of LGACC cells. (Int Rev Ophthalmol, 2022, 46:  157-161)


Key words: lacrimal gland adenoid cystic carcinoma, microRNA